Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solmaz AghaAmiri

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Molecular Therapy. Oncology|May 13, 2026
Fibulin-4 expressed in metastatic breast cancer is a target of peptide-based imaging probes and experimental therapeuticsAlexes C Daquinag, Sukhen C Ghosh, Solmaz AghaAmiri, et al.
Journal of Biomedical Optics|December 10, 2020
Development of a drug-device combination for fluorescence-guided surgery in neuroendocrine tumorsServando Hernandez Vargas, Christie Lin, Julie Voss, et al.
Biorxiv : the Preprint Server for Biology|July 4, 2025
Fibulin-4 is highly expressed in metastatic breast cancer and can serve as a target of peptide-based imaging probes and experimental therapeuticsAlexes C Daquinag, Solmaz AghaAmiri, Stephen M Farmer, et al.
Cancers|January 25, 2025
SSTR2-Targeted Theranostics in Hepatocellular CarcinomaMajid Momeny, Solmaz AghaAmiri, Servando Hernandez Vargas, et al.
Current Oncology (Toronto, Ont.)|September 26, 2025
Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic ApplicationsServando Hernandez Vargas, Solmaz Aghaamiri, Jack T Adams, et al.
Cancer Research|December 18, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Antitumor Activity in Colorectal CancerJoan Jacob, Yasuaki Anami, Peyton C High, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal CancerJoan Jacob, Yasuaki Anami, Peyton High, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Combined multiphoton microscopy and somatostatin receptor type 2 imaging of pancreatic neuroendocrine tumorsNoelle Daigle, Thomas Knapp, Suzann Duan, et al.
Molecular Pharmaceutics|September 29, 2022
High-Contrast Detection of Somatostatin Receptor Subtype-2 for Fluorescence-Guided SurgeryServando Hernandez Vargas, Solmaz AghaAmiri, Sukhen C Ghosh, et al.
Biophotonics Discovery|April 24, 2026
Investigating machine learning algorithms to classify label-free images of pancreatic neuroendocrine neoplasmsNoelle Daigle, Shuyuan Guan, Suzann Duan, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Molecular Therapy. Oncology|May 13, 2026
Fibulin-4 expressed in metastatic breast cancer is a target of peptide-based imaging probes and experimental therapeuticsAlexes C Daquinag, Sukhen C Ghosh, Solmaz AghaAmiri, et al.
Journal of Biomedical Optics|December 10, 2020
Development of a drug-device combination for fluorescence-guided surgery in neuroendocrine tumorsServando Hernandez Vargas, Christie Lin, Julie Voss, et al.
Biorxiv : the Preprint Server for Biology|July 4, 2025
Fibulin-4 is highly expressed in metastatic breast cancer and can serve as a target of peptide-based imaging probes and experimental therapeuticsAlexes C Daquinag, Solmaz AghaAmiri, Stephen M Farmer, et al.
Cancers|January 25, 2025
SSTR2-Targeted Theranostics in Hepatocellular CarcinomaMajid Momeny, Solmaz AghaAmiri, Servando Hernandez Vargas, et al.
Current Oncology (Toronto, Ont.)|September 26, 2025
Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic ApplicationsServando Hernandez Vargas, Solmaz Aghaamiri, Jack T Adams, et al.
Cancer Research|December 18, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Antitumor Activity in Colorectal CancerJoan Jacob, Yasuaki Anami, Peyton C High, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal CancerJoan Jacob, Yasuaki Anami, Peyton High, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Combined multiphoton microscopy and somatostatin receptor type 2 imaging of pancreatic neuroendocrine tumorsNoelle Daigle, Thomas Knapp, Suzann Duan, et al.
Molecular Pharmaceutics|September 29, 2022
High-Contrast Detection of Somatostatin Receptor Subtype-2 for Fluorescence-Guided SurgeryServando Hernandez Vargas, Solmaz AghaAmiri, Sukhen C Ghosh, et al.
Biophotonics Discovery|April 24, 2026
Investigating machine learning algorithms to classify label-free images of pancreatic neuroendocrine neoplasmsNoelle Daigle, Shuyuan Guan, Suzann Duan, et al.
Pageof 3